NCT05433675View on ClinicalTrials.gov

A Study of Two Macitentan Formulations in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

October 3, 2022

Conditions

Healthy

Interventions

DRUG

Macitentan

Macitentan dispersible and film-coated tablets will be administered orally as per assigned treatment sequence.

Trial Locations (1)

2650

SGS Belgium NV, Edegem

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Actelion

INDUSTRY